Ompoy, Clarence Jade F.
HRN: 22-56-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
MUPIROCIN 2%, 15G (TUBE)
10/07/2024
10/14/2024
TOPICAL
As Needed
BID
Phlebitis
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes